NSP-1047

N/A

Report date: 2023/10/11 09:10:09
NME

Base Information

Drug NameNSP-1047
Drug Alias NameNSP-1047
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 4E inhibitorsMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitorsMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors
TargetsEukaryotic translation initiation factor 4EMAP kinase-interacting serine/threonine-protein kinase MNK1MAP kinase-interacting serine/threonine-protein kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNuowo Sida Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A